Brevan Howard Capital Management LP Charles River Laboratories International, Inc. Transaction History
Brevan Howard Capital Management LP
- $9.23 Billion
- Q1 2025
A detailed history of Brevan Howard Capital Management LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 5,529 shares of CRL stock, worth $820,503. This represents 0.01% of its overall portfolio holdings.
Number of Shares
5,529
Previous 8,008
30.96%
Holding current value
$820,503
Previous $1.48 Million
43.71%
% of portfolio
0.01%
Previous 0.01%
Shares
4 transactions
Others Institutions Holding CRL
# of Institutions
648Shares Held
55MCall Options Held
695KPut Options Held
809K-
Vanguard Group Inc Valley Forge, PA6.11MShares$906 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.09MShares$755 Million0.02% of portfolio
-
Wellington Management Group LLP Boston, MA4.29MShares$636 Million0.13% of portfolio
-
Ubs Group Ag2.39MShares$355 Million0.07% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.95MShares$289 Million0.75% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $7.55B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...